Cloud Alpha Capital Management Limited Crispr Therapeutics Ag Transaction History

Cloud Alpha Capital Management Limited

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $7.27 Million - $10.3 Million	-66,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $1.41 Million - $2.27 Million	14,000 Added 26.92%	66,000 $10.7 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $5.43 Million - $10.3 Million	49,000 Added 1633.33%	52,000 $6.34 Million
Q4 2020 Mar 19, 2021	BUY	$79.67 - $173.23 $239,010 - $519,689	3,000 New	3,000 $459,000

504

57.1M

1.74M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.